KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Labcorp Holdings (LH) Operating Expenses (2016 - 2025)

Labcorp Holdings' Operating Expenses history spans 17 years, with the latest figure at $538.6 million for Q4 2025.

  • For Q4 2025, Operating Expenses fell 11.21% year-over-year to $538.6 million; the TTM value through Dec 2025 reached $2.2 billion, down 1.9%, while the annual FY2025 figure was $2.2 billion, 2.62% down from the prior year.
  • Operating Expenses for Q4 2025 was $538.6 million at Labcorp Holdings, down from $558.3 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $606.6 million in Q4 2024 and bottomed at $270.6 million in Q4 2021.
  • The 5-year median for Operating Expenses is $524.0 million (2021), against an average of $500.0 million.
  • The largest annual shift saw Operating Expenses crashed 47.93% in 2021 before it soared 76.67% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $270.6 million in 2021, then increased by 15.3% to $312.0 million in 2022, then surged by 76.67% to $551.2 million in 2023, then increased by 10.05% to $606.6 million in 2024, then dropped by 11.21% to $538.6 million in 2025.
  • Per Business Quant, the three most recent readings for LH's Operating Expenses are $538.6 million (Q4 2025), $558.3 million (Q3 2025), and $583.4 million (Q2 2025).